Publications by authors named "Jason Kemner"

Claim this Profile
A
Adherence and persistence to tafamidis treatment among Medicare beneficiaries in the presence of a patient assistance program.
Haechung Chung, Cera Cantu, Cindi Pankratova, Jason Kemner, Jose Alvir

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx).
Sepideh Attal, Jason Kemner, Jose Alvir, Sebastian Barth, Sofia Schuessler

Cardiol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States.
Rahul Bhambri, A Carmine Colavecchia, Marianna Bruno, Yong Chen, Jose Alvir, Jason Kemner

Am J Cardiovasc Drugs· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort.
Anuja Roy, Andrew Peterson, Nick Marchant, Jose Alvir, Rahul Bhambri, Jason Kemner

J Manag Care Spec Pharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database.
Anuja Roy, Andrew Peterson, Nick Marchant, Jose Alvir, Rahul Bhambri, Jason Kemner

Patient Prefer Adherence· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter by Rozenbaum et al Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy".
Mark H Rozenbaum, Jason Kemner, Bhash Parasuraman

Circulation· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of treatments for vertebral compression fractures.
Avram A Edidin, Kevin L Ong, Edmund Lau, Jordana K Schmier, Jason E Kemner

Appl Health Econ Health Policy· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
Bruce Stuart, Amy Davidoff, Jennifer Lloyd, Thomas Shaffer, J Samantha Shoemaker, Jason Kemner

Am J Geriatr Pharmacother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
Derek Weycker, Oleg Sofrygin, Jason E Kemner, Stephen I Pelton, Gerry Oster

Vaccine· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
Cynthia L Leibson, William J Barbaresi, Jeanine Ransom, Robert C Colligan, Jason Kemner

Ambul Pediatr· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis.
Jason E Kemner, Maureen J Lage

Ann Gen Psychiatry· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study.
Jason E Kemner, H Lynn Starr, Patrick E Ciccone, Christa G Hooper-Wood, R Steve Crockett

Adv Ther· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of methylphenidate formulation on treatment patterns and use of emergency room services.
Jason E Kemner, Maureen J Lage

Am J Health Syst Pharm· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.
H Lynn Starr, Jason Kemner

J Natl Med Assoc· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
Steven C Marcus, George J Wan, Jason E Kemner, Mark Olfson

Arch Pediatr Adolesc Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Productivity and medical costs of diabetes in a large employer population.
Scott Ramsey, Kent H Summers, Stephanie A Leong, Howard G Birnbaum, Jason E Kemner

Diabetes Care· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis